Ondansetron
Product Images NDC 63304-347

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Ondansetron (NDC 63304-347). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Rnabaxy Pharmaceuticals Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Bottle Label 4 mg (Ondanbtlbl4mg)

ONDANSETRON 4 mg orally disintegrating tablets by Rnabaxy Pharmaceuticals Inc. The label indicates a package containing 30 tablets. The product is identified for oral administration as an orally disintegrating tablet, with usage and storage instructions included on the label.*

FDA Label Image

Bottle Label 8 mg (Ondanbtlbl8mg)

Ondansetron 8 mg orally disintegrating tablets, USP in a 30-tablet package from Ranbaxy Pharmaceuticals Inc. The label includes dosage form, strength, quantity, storage instructions, and basic usage information. It also displays the NDC number and barcode.*

FDA Label Image

Structure (Structure)

Chemical structure of the active ingredient Ondansetron. The diagram depicts the molecular structure with its characteristic fused rings and side chains, including nitrogen and oxygen atoms.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.